Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Procedures for Recording and Interpreting Disintegration Test Results

Posted on By

SOP for Procedures for Recording and Interpreting Disintegration Test Results

Guidelines for Recording and Interpreting Disintegration Test Results

1) Purpose

The purpose of this SOP is to provide procedures for accurately recording and interpreting the results of disintegration tests performed on capsules.

2) Scope

This SOP applies to all disintegration tests conducted on capsules within the pharmaceutical manufacturing facility.

3) Responsibilities

The Quality Control (QC) department is responsible for recording and interpreting the results of disintegration tests.

4) Procedure

  1. Recording Disintegration Test Results:
    1. Immediately record the disintegration time for each capsule in the disintegration test logbook upon completion of the test.
    2. Ensure all entries are legible and accurate, including the date, time, and operator’s initials.
    3. Use only approved and calibrated instruments for measuring disintegration times.
  2. Interpreting Disintegration Test Results:
    1. Compare the recorded disintegration times to the established acceptance criteria.
    2. Document any instances where the disintegration time falls outside the acceptable range.
    3. Investigate any out-of-specification results according to the relevant SOP for handling deviations.
  3. Data Review and Approval:
    1. The QC manager or designee must review and approve all recorded disintegration test results.
    2. Ensure that all deviations are properly documented and investigated before final approval.
    3. Sign and date the logbook to confirm the review and approval of the test results.
  4. Documentation and Archiving:
    1. Maintain all disintegration test records in the
designated logbook and ensure they are stored in a secure, easily retrievable location.
  • Archive the logbook according to the facility’s document retention policy.
  • Ensure that electronic records, if used, are backed up regularly and comply with regulatory requirements for data integrity.
  • Periodic Review:
    1. Conduct periodic reviews of disintegration test data to identify trends and ensure ongoing compliance with quality standards.
    2. Update the disintegration test procedure and acceptance criteria as necessary based on the review findings.
  • 5) Abbreviations, if any

    QC: Quality Control

    6) Documents, if any

    Disintegration Test Logbook, Deviation Reports, and Data Review Records

    7) Reference, if any

    Relevant regulatory guidelines such as ICH Q7 and FDA Guidance for Industry

    8) SOP Version

    Version 1.0

    See also  Capsule Formulation: SOP for Documentation and Record-Keeping
    Capsule Formulation Tags:Capsule Batch Record, Capsule Blending, Capsule Cleaning Validation, Capsule Coating, Capsule Deviation Investigation, Capsule Dosage Form, Capsule Encapsulation, Capsule Equipment Qualification, Capsule Filling, Capsule Formulation SOP, Capsule Inspection Procedure, Capsule Integrity, Capsule Manufacturing, Capsule Mixing, Capsule Polishing, Capsule Production, Capsule Quality Control, Capsule Sampling, Capsule Shell Inspection, Capsule Weight Check

    Post navigation

    Previous Post: SOP for Personnel Hygiene Practices in Ointment Formulation
    Next Post: SOP for Moisture Content Control

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version